During three full days of 26,000 one-to-one meetings, mergers are made, strategies are mapped, funding is found, and significant trends begin to emerge. For the fourth year, Pharma Intelligence has analyzed the types of alliances, the scope of dealmaking activity, and the myriad opportunities that continue to drive drug development at each BIO-Europe international partnering event. The analyses found in the Pharma Partnering Trends Revealed: 2019 Edition are the result of the thorough examination of more than 150,000 meetings that took place between 2012 and 2018.
- Strategic partnerships that resulted from negotiations
- The companies pairing up to develop the most sought-after therapies
- Therapeutic areas garnering the most attention
- How partnering meetings impact therapies, treatments, and cures